Trials / Completed
CompletedNCT03598088
Safety and Acceptability Study of a Non-Hormonal Ring
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Daré Bioscience, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a feasibility, multi-center, open-label, non-significant risk device study for a non-hormonal contraceptive ring.
Detailed description
The purpose of this clinical trial is to assess the ability of Ovaprene™ to prevent sperm from penetrating midcycle cervical mucus. In addition, safety, release of ingredients, acceptability and fit will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ovaprene | non-hormonal contraceptive ring |
Timeline
- Start date
- 2018-05-23
- Primary completion
- 2019-10-17
- Completion
- 2019-11-15
- First posted
- 2018-07-26
- Last updated
- 2022-06-08
- Results posted
- 2022-06-08
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03598088. Inclusion in this directory is not an endorsement.